Purification products and on-site service for guaranteed cost reductions Veolia Services Southern Africa (VSSA), the global specialist in water purification and management, has a range of solutions for the pharmaceutical industry that deliver guaranteed cost reduction, enhanced utilities availability and regulatory compliance. T he pharmaceutical industry is heavily regulated, and all manufac- turers must meet the compliance guidelines set out by the various
most from every drop of water’,” explains Leon Xu, Business Development manager for VSSA. Water source quality remains a potential risk factor for plant performance. “With aging municipal water treatment infrastruc- ture and a growing urban population, it has become increasingly challenging for the mu- nicipal works to maintain consistent qual- ity at all times. To achieve uninterrupted production of purified water for production use, pharmaceutical manufacturers must ensure that their input water is monitored vigilantly, and that their purified water plants are operated and serviced diligently,” adds Miles Murray, director for Business Development at VSSA. Veolia’s solutions for the pharma- ceutical industry deliver cost- savings and regulatory compliance,
proving access to high quality utilities, especially water. “All our solutions for compendial water production are designed to meet the product quality specifications of all pharmacopeia requirements and guide- lines, giving customers peace of mind and compliance assurance,” says Xu. Veolia recently implemented an ultrafil- tration system for a pharmaceutical com- pany whose purified water treatment plants were failing microbial quality tests. After implementing Veolia’s ultrafiltration system and replacing the purified water treatment system with Veolia Orion ® technology, the company enjoys a secured supply of purified water, resulting from the robust treatment process and hot water sanitisation capabil- ity that were put in place. Orion ® is Veolia’s flagship technology that brings together all scientific advances made by Veolia for the pharmaceutical industry. This is a skid-mounted, multi- technology purified water production sys- tem that offers softening, reverse osmosis and continu- ous electrodeionisation
pharmacopeia and industry bodies. The qual- ity and purity of water – a key component of many medicines – and an essential resource for plant cooling and cleaning, must be guar- anteed. However, access to clean water is be- coming increasingly costly and difficult to secure. “Water security and input cost are important sustainability factors for phar- maceutical manufacturers to consider. It is therefore crucial to employ advanced technologies that enable one to ‘get the
as well as im-
(CEDI) that can be fully or partially hot water sanitised. “Depending on the model, the Orion ® system produces be- tween 500 and 2 000 litres of purified water per hour. As of today, more than 300 systems have been installed glob- ally,” adds Murray. Sustainability is at
the core of Veolia’s water technologies for the pharmaceutical indus- try. Consider the Orion ® S-Series, which has a recycle mode feature that limits water wastage during purification. During product recy-
The Orion ® purified water production system can deliver between 500 and 20 000 ℓ of purified water per hour.
14 ¦ MechChem Africa • September-October 2022
Made with FlippingBook flipbook maker